Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $33.45M | $61.52M | -45.62% |
Operating Income | $-315.53M | $-309.34M | -2.00% |
Net Income | $-286.39M | $-275.32M | -4.02% |
EPS (Basic) | $-3.49 | $-3.63 | +3.86% |
EPS (Diluted) | $-3.49 | $-3.63 | +3.86% |
R&D Expense | $266.12M | $297.3M | -10.49% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $1.17B | $1.29B | -9.23% |
Current Assets | $945.53M | $1.04B | -9.04% |
Total Liabilities | $380.05M | $511.59M | -25.71% |
Current Liabilities | $166.24M | $220.37M | -24.56% |
Stockholders' Equity | $791.32M | $778.94M | +1.59% |
Cash & Equivalents | $230.2M | $169.05M | +36.18% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-270.88M | $-284.27M | +4.71% |
Investing Cash Flow | $58.73M | $-26.26M | +323.65% |
Financing Cash Flow | $4.29M | $242.74M | -98.23% |
D&A | $16.48M | $14.65M | +12.51% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -943.3% | -502.9% | -440.41% |
Net Margin | -856.1% | — | — |
ROE | -36.2% | — | — |
ROA | -24.4% | — | — |
Current Ratio | $5.688 | — | — |
Debt to Equity | $0.48 | — | — |
Other companies in Biotechnology